| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00421967 2006-004638-33 Details | 2008-05-07 Interventional | 4 | 80 | Epinephrine Epinephryl bora… Ketorolac Ketorolac Trome… Racepinephrine Ropivacaine Arthroplasty, R… | Interim analysis - | |||
| NCT00222651 Details | 2008-05-06 Interventional | 2 | - | Tenecteplase Embolism Pulmonary Embol… Ventricular Dys… | competitor study about to start - | |||
| NCT00607711 Details | 2008-05-05 Interventional | 1 | - | Ifosfamide Isophosphamide … Advanced Cancer | IND was withdrawn - | |||
| NCT00266149 Details | 2008-04-24 Interventional | 3 | - | Lamotrigine Epilepsy | - - | |||
| NCT00369031 2005-005983-10 Details | 2008-04-15 Interventional | 1 | 31 | polysaccharide-… HIV Infections | Safety issues - | |||
| NCT00642135 2005-004418-33 Details | 2008-04-10 Interventional | 3 | 80 | Ophthalmic Solu… Oxymetazoline Phenylephrine Tropicamide Premature Birth Retinal Anomali… | The total number of patients has been reached. - | |||
| NCT00333060 Details | 2008-04-02 Interventional | 2 | - | Ophthalmic Solu… Cataract Epiretinal Memb… Retinal Perfora… Macular Hole | - - | |||
| NCT00645255 Details | 2008-03-27 Interventional | 3 | 466 | Sibutramine Weight Loss Obesity | - - | |||
| NCT00644306 Details | 2008-03-26 Interventional | 3 | 232 | Melphalan Prednisone Thalidomide Multiple Myelom… Neoplasms, Plas… Newly Diagnosed… | survival advantage demonstrated - | |||
| NCT00638482 Details | 2008-03-19 Interventional | 2/3 | 10 | Hydrochlorothia… Dent Disease Kidney Calculi Nephrolithiasis Dent's Disease | terminated - | |||
| NCT00510471 Details | 2008-03-18 Interventional | 2 | - | Antibodies Immunoglobulin … Immunoglobulins Immunoglobulins… Lymphoma Lymphoma, Non-H… Non-Hodgkin's L… | - - | |||
| NCT00263965 2004-000350-24 Details | 2008-03-17 Interventional | 2 | - | Metformin Diabetes Mellit… Insulin Resista… Type 2 Diabetes | The development program has been terminated - | |||
| NCT00255541 Details | 2008-03-17 Interventional | 3 | - | Glyburide Diabetes Mellit… Type 2 Diabetes | The development program has been terminated - | |||
| NCT00251940 2004-001144-71 Details | 2008-03-17 Interventional | 3 | - | Glyburide Diabetes Mellit… Type 2 Diabetes | The development program has been terminated - | |||
| NCT00624481 Details | 2008-03-13 Interventional | 2 | - | Teriparatide Bone Diseases, … Osteoporosis Osteopenia | - - | |||
| NCT00376493 Details | 2008-03-13 Interventional | 4 | 56 | Doxycycline Metronidazole Abortion, Septi… Septic Abortion | The rate of cure in both arms was higher than expected - | |||
| NCT00271804 Details | 2008-03-13 Interventional | 1 | - | Bortezomib Myelodysplastic… Preleukemia Myelodysplastic… | New study with lenalidomide pending - | |||
| NCT00431028 Details | 2008-03-07 Interventional | 1/2 | 140 | Ciprofloxacin Triamcinolone Bacterial Infec… Cataract Inflammation | Terminated - | |||
| NCT00085761 Details | 2008-03-06 Interventional | 3 | - | Capsaicin HIV Infections Nervous System … Peripheral Nerv… Pain | Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes - | |||
| NCT00622687 Details | 2008-02-25 Interventional | 2 | 50 | Iloprost Scleroderma, Di… Scleroderma, Sy… Sclerosis Systemic Sclero… | sufficient number to reach the primary endpoint and as planned - |